Field Trip Launches Site Management Organization (SMO) Services, Hires Stéphan Côté as Head of Quality
14 déc. 2021 07h30 HE
|
Field Trip Health, Ltd.
TORONTO, Dec. 14, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (NASDAQ: FTRP, TSX: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, today announced...
Field Trip Health Ltd. to Participate in Upcoming Conferences in December 2021
01 déc. 2021 07h30 HE
|
Field Trip Health, Ltd.
TORONTO, Dec. 01, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies,...
Field Trip Health Ltd. Reports Second Fiscal Quarter 2022 Financial Results and Provides Business Update
15 nov. 2021 18h05 HE
|
Field Trip Health, Ltd.
Announced plans to advance FT-104, its novel psychedelic compound, to clinic for Treatment-Resistant Depression and Postpartum Depression as the lead indications.Initiated a new pipeline research...
Field Trip Health Ltd. to Participate in Upcoming Conferences in November 2021
03 nov. 2021 07h30 HE
|
Field Trip Health, Ltd.
TORONTO, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies,...
Field Trip Health Ltd. Schedules Second Fiscal Quarter 2022 Financial Results Conference Call for Tuesday, November 16, 2021 at 8:30 AM ET
02 nov. 2021 07h30 HE
|
Field Trip Health, Ltd.
TORONTO, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies,...
Field Trip Health Ltd. Continues Expansion With Psychedelic-Assisted Therapy Centers in Seattle, Vancouver and Fredericton
19 oct. 2021 07h55 HE
|
Field Trip Health, Ltd.
TORONTO, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (NASDAQ: FTRP, TSX: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today...
Field Trip Health Announces Voting Results From the Annual General and Special Meeting of Shareholders
24 sept. 2021 18h10 HE
|
Field Trip Health, Ltd.
TORONTO, Sept. 24, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; Nasdaq: FTRP) ("Field Trip"), today announced the voting results from its Annual General and Special Meeting...
Field Trip Health Ltd. to Participate in Four Investor Conferences in September
10 sept. 2021 08h48 HE
|
Field Trip Health, Ltd.
TORONTO, Sept. 10, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; Nasdaq: FTRP) ("Field Trip"), a leader in the development and delivery of psychedelic therapies, today...
Field Trip Health Ltd. to Pursue Treatment Resistant Depression and Postpartum Depression as Indications for FT-104
09 sept. 2021 07h30 HE
|
Field Trip Health, Ltd.
TORONTO, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; NASDAQ: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies,...
Field Trip Health Ltd. Announces Launch Of “Kap Co-Operative” Program, Enabling Independent Psychedelic Therapists To Practice At Its Field Trip Health Centers; Also Launches Training Programs To Educate A New Generation Of Psychedelic Clinicians
31 août 2021 07h55 HE
|
Field Trip Health, Ltd.
The KAP Co-op program gives eligible therapists the ability to provide ketamine-assisted psychotherapy (KAP) to their patients at Field Trip Health Centers utilizing Field Trip’s medical teams for...